https://www.aptitudehealth.com/oncology-news/bioimpedance-spectroscopy-bis-for-lymphedema-screening-after-breast-cancer-treatment/
there’s a survey on what screening tool that 45 breast care physicians used. Was interesting to see BIS mentioned by 45 %, 30% didn’t screen, only 4 % used perometry and 11% tape. There was a “other” section which was 9% and also probably included some sozo use. But it showed BIS was atleast 4 times more utilised than the closest competitor and this should only increase with more awareness and hospitals starting Lymphedema prevention programs and trying to improve survivorship. Impedimed is clearly the first mover and top dog in lymphedema prevention
Media, page-85
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
-0.002(2.63%) |
Mkt cap ! $149.7M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.6¢ | 7.4¢ | $76.52K | 1.025M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 192981 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 285174 | 1 |
View Market Depth
| Last trade - 15.51pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.4¢ |
Change
-0.002 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 7.6¢ | 7.4¢ | 717317 | ||
| Last updated 15.38pm 04/06/2024 ? | |||||
| IPD (ASX) Chart |